Mota-Engil Central Europe took over on Thursday (16/08/2018) the construction site of the Research and Development Center for Innovative Medicines. A modern research facility will be located at Podole street in Kraków-Ruczaj, in the neighborhood of the headquarters of the investor Selvita S.A. It is polish, one of the largest biotechnology companies in Europe, conducting research on new oncology drugs. Mota-Engil Central Europe has 15 months to complete the investment.
- Cooperation with a modern company, specializing in the implementation of research projects innovations, perfectly fits into our strategy of diversifying the company's activity. As the Mota-Engil Group, we have extensive experience in the implementation of complex and impressive civil construction projects in Europe. Cooperation with Selvita S.A. allows us to expand our offer addressed to a commercial client in Poland, but also gives the privilege to participate in an important scientific venture. Today there is no other important area for the development of modern medicine serving people for the treatment of cancer - says Piotr Bienias, CFO Mota-Engil Central Europe.
Information about the project:
• Total area: 10 015 m2
• Usable area: 8,270 m2
• Number of storeys: 6
Including above - ground: 5
Including underground: 1
• Building height: 24.52 m
• Building length: 46.5 m
• Building width: 36.55 m
• Building area: 1 699 m2
• Gross volume: 47 350 m3